Skip to main content

Skin Quality Improvement

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
1 program
Restylane Skinboosters Vital LidocaineN/A1 trial
Active Trials
NCT07047638Active Not Recruiting171Est. Jul 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
GaldermaRestylane Skinboosters Vital Lidocaine

Clinical Trials (1)

Total enrollment: 171 patients across 1 trials

NCT07047638GaldermaRestylane Skinboosters Vital Lidocaine

A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine

Start: Jul 2025Est. completion: Jul 2027171 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.